|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 242.80 EUR | -2.88% |
|
-6.24% | +1.97% |
| 07-09 | UK Life Sciences Hits GBP3 Billion Investment Milestone | MT |
| 07-03 | Berenberg Updates Price Target, Estimates for UCB on Recent Pipeline Deals | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| UCB | Biopharmaceuticals | -2.88% | -6.24% | +1.97% | +40.96% | +166.19% | 54.4B |  | | |
- Stock Market
- Stocks
- UCB Stock
- Charts UCB
- Comparison Chart
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
